BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 4, 2011
View Archived Issues
Long-term daclizumab therapy analyzed in patients with MS
Read More
Phosphodiesterase 5 inhibitor improves portal hypertension in open-label trial
Read More
Boceprevir improves hepatitis C treatment in patients coinfected with HIV
Read More
Ondansetron is effective in treating diarrhea-predominant irritable bowel syndrome
Read More
Telormedix reports promising preclinical data on topical skin cancer treatment
Read More
Clinuvel's Scenesse shows clinically relevant prophylactic effect in EPP
Read More
Chelsea Therapeutics reports interim results from phase II study of CH-4051
Read More
New mTOR inhibitors disclosed by Auspex Pharmaceuticals
Read More
RespiVert prepares novel MAP kinase p38 inhibitors
Read More
Life Sciences Research Partners and Flanders' VIB claim new cell-based ischemia therapy
Read More
Tibotec presents novel HIV integrase inhibitors
Read More
Senesco initiates dosing in phase Ib/IIa SNS01-T study
Read More
Tetraphase Pharmaceuticals synthesizes new antibacterial agents
Read More
Avanir Pharmaceuticals enrolls first patient in PRIME study
Read More
Optimer files NDS for Dificid in Canada
Read More
Interim analysis of MDV-3100 prostate cancer study shows beneficial survival data
Read More
BMS and Aslan enter agreement for anticancer compound
Read More
RedHill Biopharma plans RHB-102 bioequivalence study
Read More
Korean company patents new glucagon GLP-1 receptor agonists
Read More
Novel casein kinase II inhibitors reported by BMS
Read More
Researchers at Lilly describe novel cannabinoid CB2 receptor agonists
Read More
PharmaGap plans in vivo efficacy testing of GAP-107B8
Read More
FDA accepts VIVUS' resubmitted Qnexa NDA
Read More
Atlab Pharma and BZL Biologics enter licensing agreement for [177Lu]-J591
Read More
Discovery Labs' lucinactant gains European orphan drug status
Read More